Patrick Verta
Abbott Laboratories
14 Papers
131 Citations
Patrick Verta is an academic researcher from Abbott Laboratories. The author has contributed to research in topics: Stroke & Carotid endarterectomy. The author has an hindex of 12, co-authored 14 publications. Previous affiliations of Patrick Verta include Columbia University Medical Center.
Chat about Author
Papers
Protected carotid stenting in high-surgical-risk patients: the ARCHeR results
William A. Gray,L. Nelson Hopkins,Sanjay Yadav,Thomas E. Davis,Mark H. Wholey,Richard Atkinson,Alberto Cremonesi,Ronald M. Fairman,Gary Walker,Patrick Verta,Jeffrey J. Popma,Renu Virmani,David J. Cohen +12 more
TL;DR: The ARCHeR results demonstrate that extracranial carotid artery stenting with embolic filter protection is not inferior to historical results of endarterectomy and suggest that carotids in arteries stenting is a safe, durable, and effective alternative in high-surgical-risk patients.
439
The CAPTURE registry: Predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting
William A. Gray,Jay S. Yadav,Patrick Verta,Andrea Scicli,Ronald M. Fairman,Mark H. Wholey,L. Nelson Hopkins,Richard Atkinson,Rod Raabe,Stanley Barnwell,Richard M. Green +10 more
TL;DR: Predictors of outcomes in carotid stenting in the earliest and largest prospective multicenter neurologist‐adjudicated experience in the United States post device approval are examined.
234
First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease
Johannes Lammer,Marc Bosiers,Thomas Zeller,Martin Schillinger,Els Boone,Margo J. Zaugg,Patrick Verta,Lei Peng,Xingyu Gao,Lewis B. Schwartz +9 more
TL;DR: The everolimus-eluting self-expanding nitinol stent can be successfully implanted in patients with severe peripheral arterial disease with favorable outcomes and clinical improvements observed in the majority of patients.
159
Influence of Site and Operator Characteristics on Carotid Artery Stent Outcomes : Analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) Clinical Study
William A. Gray,Kenneth Rosenfield,Michael R. Jaff,Seemant Chaturvedi,Lei Peng,Patrick Verta,Capture Investigators +6 more
TL;DR: Outcomes from the largest prospectively gathered, independently adjudicated, multicenter CAS study indicate that CAS can be safely performed in a variety of hospital settings by physicians with various specialties.
151
The CAPTURE registry: analysis of strokes resulting from carotid artery stenting in the post approval setting: timing, location, severity, and type.
Ronald M. Fairman,William A. Gray,Andrea Scicli,Olivia Wilburn,Patrick Verta,Richard Atkinson,Jay S. Yadav,Mark H. Wholey,L. Nelson Hopkins,Rod Raabe,Stanley Barnwell,Richard M. Green +11 more
TL;DR: Strokes related to CAS seem to become clinically apparent after the procedure but before discharge in the majority of events, Nevertheless, a significant minority of stroke symptoms follows discharge from the hospital, typically after 24 hours.
133